Why an alternate recipient list for heart transplantation is not a form of ageism

K A Bramstedt1

  • 1Monash University, Australia.

New Zealand Bioethics Journal
|December 14, 2004
PubMed

Insights

Utilizing marginal donor hearts for transplantation yields positive outcomes. An alternate recipient list (ARL) ethically prioritizes patients with the capacity to benefit, representing responsible technology stewardship, not ageism.

Area of Science:

  • Transplantation ethics
  • Organ allocation
  • Medical ethics

Background:

  • Marginal donor hearts are increasingly used in organ transplantation.
  • Clinical outcomes with marginal hearts are often favorable.
  • Concerns exist regarding the ethical implications of allocating these hearts to specific recipient groups, such as the elderly.

Purpose of the Study:

  • To ethically evaluate the use of an alternate recipient list (ARL) for heart transplantation.
  • To determine if the ARL constitutes ageism or a justifiable allocation strategy.
  • To analyze the ethical principles governing organ allocation.

Main Methods:

  • Ethical analysis of the organ allocation process.
  • Reflection on the goals of medicine and transplantation.
  • Examination of outcome data in conjunction with ethical principles.

Main Results:

  • Outcome data alone is insufficient to justify the ethical use of an ARL.
  • Ethical principles support the ARL as a method of technology stewardship.
  • The ARL facilitates transplant eligibility for recipients with the capacity to benefit.

Conclusions:

  • An alternate recipient list for heart transplantation is ethically justifiable.
  • The ARL is a form of technology stewardship, not ageism.
  • Prioritizing recipients based on their capacity to benefit aligns with medical ethics.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...